Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1NET 1Gastrointestinal 1Endocrine 1

Conditions

Carcinoma, Hepatocellular 2Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Digestive System Neoplasms 1Desmoid Tumors 1Colorectal Neoplasms 1Adrenocortical Carcinoma 1

Interventions

Trastuzumab 2Cyclophosphamide 2tipifarnib 1relacorilant 1pembrolizumab 1fludarabine phosphate 1entinostat 1avelumab 1Suramin 1Specimen Handling 1Nivolumab 1N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride 1Magnetic Resonance Spectroscopy 1Interleukin-13 1Interleukin-12 Subunit p35 1Interleukin-12 1IPI-549 1Fluorodeoxyglucose F18 1E-7386 1Doxorubicin 1Cytoreduction Surgical Procedures 1Cisplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Adrenocortical Carcinoma × E-7386 × Clear all
NCT03833700 2026-02-27

A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

Eisai Inc.

Phase 1 Active not recruiting
70 enrolled
EndocrineGastrointestinalNETSarcoma

Gastro-enteropancreatic neuroendocrine tumor, Digestive System Neoplasms, Carcinoma, Hepatocellular, Colorectal Neoplasms, Desmoid Tumors, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡